Robert W. Baird Reaffirms Buy Rating for HealthSouth Corporation (HLS)

Robert W. Baird reiterated their buy rating on shares of HealthSouth Corporation (NYSE:HLS) in a report released on Monday. They currently have a $55.00 target price on the stock.

A number of other research analysts have also commented on HLS. KeyCorp initiated coverage on shares of HealthSouth Corporation in a research report on Thursday, June 15th. They set a sector weight rating for the company. BidaskClub raised shares of HealthSouth Corporation from a sell rating to a hold rating in a research report on Saturday, June 17th. Zacks Investment Research lowered shares of HealthSouth Corporation from a buy rating to a hold rating in a research report on Monday, July 3rd. Royal Bank Of Canada reissued a buy rating and issued a $53.00 price target on shares of HealthSouth Corporation in a research report on Wednesday, July 5th. Finally, ValuEngine raised shares of HealthSouth Corporation from a hold rating to a buy rating in a research report on Friday, July 7th. Two analysts have rated the stock with a sell rating, five have assigned a hold rating and four have issued a buy rating to the company’s stock. The stock has a consensus rating of Hold and a consensus price target of $50.38.

Shares of HealthSouth Corporation (NYSE:HLS) traded down 0.85% during mid-day trading on Monday, reaching $45.32. The company had a trading volume of 73,300 shares. HealthSouth Corporation has a 52-week low of $36.97 and a 52-week high of $49.71. The company’s 50-day moving average price is $45.09 and its 200-day moving average price is $45.33. The company has a market capitalization of $4.47 billion, a PE ratio of 16.52 and a beta of 0.58.

HealthSouth Corporation (NYSE:HLS) last announced its quarterly earnings data on Monday, July 31st. The company reported $0.71 EPS for the quarter, beating the Zacks’ consensus estimate of $0.68 by $0.03. The business had revenue of $981.30 million during the quarter, compared to analyst estimates of $976.46 million. HealthSouth Corporation had a net margin of 6.70% and a return on equity of 25.07%. The firm’s revenue for the quarter was up 6.6% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.69 earnings per share. On average, analysts forecast that HealthSouth Corporation will post $2.71 earnings per share for the current fiscal year.

TRADEMARK VIOLATION NOTICE: This article was originally posted by Sports Perspectives and is the sole property of of Sports Perspectives. If you are accessing this article on another site, it was illegally stolen and republished in violation of U.S. & international copyright and trademark laws. The legal version of this article can be accessed at https://sportsperspectives.com/2017/10/12/robert-w-baird-reaffirms-buy-rating-for-healthsouth-corporation-hls.html.

The firm also recently declared a quarterly dividend, which will be paid on Monday, October 16th. Investors of record on Monday, October 2nd will be given a $0.25 dividend. This represents a $1.00 annualized dividend and a yield of 2.19%. The ex-dividend date of this dividend is Friday, September 29th. This is a positive change from HealthSouth Corporation’s previous quarterly dividend of $0.24. HealthSouth Corporation’s dividend payout ratio is 36.76%.

In other news, CEO Mark J. Tarr sold 22,625 shares of the firm’s stock in a transaction that occurred on Monday, August 7th. The shares were sold at an average price of $43.00, for a total transaction of $972,875.00. Following the completion of the sale, the chief executive officer now owns 283,134 shares of the company’s stock, valued at $12,174,762. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Corporate insiders own 1.60% of the company’s stock.

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Vanguard Group Inc. increased its holdings in shares of HealthSouth Corporation by 4.6% during the second quarter. Vanguard Group Inc. now owns 7,532,456 shares of the company’s stock worth $364,571,000 after buying an additional 328,081 shares in the last quarter. William Blair Investment Management LLC increased its holdings in shares of HealthSouth Corporation by 13.9% during the second quarter. William Blair Investment Management LLC now owns 4,302,756 shares of the company’s stock worth $208,253,000 after buying an additional 525,767 shares in the last quarter. State Street Corp increased its holdings in shares of HealthSouth Corporation by 7.5% during the second quarter. State Street Corp now owns 3,129,781 shares of the company’s stock worth $151,479,000 after buying an additional 219,306 shares in the last quarter. Voya Investment Management LLC increased its holdings in shares of HealthSouth Corporation by 4.4% during the second quarter. Voya Investment Management LLC now owns 1,621,585 shares of the company’s stock worth $78,485,000 after buying an additional 68,486 shares in the last quarter. Finally, Bank of New York Mellon Corp increased its holdings in shares of HealthSouth Corporation by 1.6% during the second quarter. Bank of New York Mellon Corp now owns 1,458,636 shares of the company’s stock worth $70,597,000 after buying an additional 23,480 shares in the last quarter. 93.05% of the stock is owned by institutional investors.

About HealthSouth Corporation

HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company manages its operations through segments, including inpatient rehabilitation, and home health and hospice.

Analyst Recommendations for HealthSouth Corporation (NYSE:HLS)

Receive News & Ratings for HealthSouth Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthSouth Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply